Similar content being viewed by others
This article is cited by
-
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1
Signal Transduction and Targeted Therapy (2024)
-
Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine
Scientific Reports (2024)
-
A sustainable approach to universal metabolic cancer diagnosis
Nature Sustainability (2024)
-
Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity
Signal Transduction and Targeted Therapy (2024)
-
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
Nature Communications (2024)